Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting

Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting—introduction

Published:2018-03 Issue:S1 Volume:26 Page:3-4
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Aapro Matti

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-018-4147-8.pdf

Reference7 articles.

1. Navari RM, Aapro M (2016) Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. N Engl J Med 374:1356–1367. https://doi.org/10.1056/NEJMra1515442

2. Roila F, Molassiotis A, Herrstedt J, participants of the MASCC/ESMO Consensus Conference Copenhagen 2015 et al (2016) 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Ann Oncol 27(suppl 5):v119–v133. https://doi.org/10.1093/annonc/mdw270

3. Grunberg SM, Osoba D, Hesketh PJ et al (2005) Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity—an update. Support Care Cancer 13:80–94. https://doi.org/10.1007/s00520-004-0718-y

4. Abdel-Rahman O (2016) Neurokinin-1 inhibitors in the prevention of nausea and vomiting from highly emetogenic chemotherapy: a network meta-analysis. Ther Adv Med Oncol 8:396–406. https://doi.org/10.1177/1758834016654902

5. American Society of Clinical Oncology. Top 5 Advances in Modern Oncology. Available at: https://www.asco.org/research-progress/cancer-progress/top-5-advances-modern-oncology . Accessed 27 June 2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Propranolol attenuates the establishment of conditioned context aversions: differential effects compared to MK-801 in an animal model of anticipatory nausea and vomiting;Behavioural Pharmacology;2024-06-07

2. Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel;Drug Safety;2023-08-08

3. Effects of the food additive monosodium glutamate on cisplatin‐induced gastrointestinal dysmotility and peripheral neuropathy in the rat;Neurogastroenterology & Motility;2020-10-28

4. Opportunities for cannabis in supportive care in cancer;Therapeutic Advances in Medical Oncology;2019-01